Compare Novavax Inc (NVAX) vs Prologis Inc (PLD) Price & Performance

Novavax IncTrade

Prologis IncTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Prologis Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Prologis Inc trades at $151.05 (market cap $137.50B). The key difference: Prologis Inc is far larger — about 105.8× Novavax Inc's market cap, and Prologis Inc pays a 2.9% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

	NVAX	PLD
Market Cap	$1.30B	$137.50B
Sector	Health	Real Estate
52-Week High	$11.19	$149.96
52-Week Low	$6.22	$104.08
Enterprise Value	$800.50M	$172.18B
Dividend Yield	—	2.9%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVAX

View details →

PLD

Jefferies questions if Segro can meet growth targets alone as Prologis takeover deadline nearsProactive Investors · 13 hours agoNeutral Prologis pressures SEGRO with takeover bid deadline looming at £13.5bn offerProactive Investors · 18 hours agoNeutral Prologis raises £13.5bn SEGRO bid with £2.7bn cash, but SEGRO board rejects it againProactive Investors · 1 day agoNeutral View details →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

About Prologis Inc

Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.